Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

SHPCX vs. PBE: which is better?

Bottom line

SHPCX vs PBE: the short answer

SHPCX (Health & Biotechnology Portfolio) and PBE (Invesco Biotechnology & Genome ETF) are both mutual funds.

PBE is cheaper at 0.59% vs 3.6% — a difference of $301 a year per $10,000 invested.

Over five years, SHPCX returned +3.7% a year vs +3.4% for PBE (reporting dates differ).

Updated Nov 19, 2026

SHPCX vs PBE side by side

SHPCXPBE
TypeMutual fundETF
Fund familySaratoga AdvantageInvesco
CategoryTechnology SectorTechnology Sector
Expense ratio3.6%0.59%
Annual cost per $10k$360$59
10-yr cost on $10k (prospectus)$3,862$738
Max front load0%None
12b-1 fee——
1-yr return−1.3%+24.7%
5-yr return (annualized)+3.7%+3.4%
10-yr return (annualized)+4.1%+5.2%
Best quarter+15.0%+25.3%
Worst quarter−13.0%−24.3%
Net assets (fund)$10.5M$281.9M
Number of holdings2933
Portfolio turnover22%103%
Returns as ofDec 31, 2024Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearSHPCXPBEDifference
2024−0.3%+1.1%−1.4%
2023−0.9%+3.7%−4.6%
2022+1.4%−10.8%+12.2%
2021+16.0%+1.6%+14.5%
2020+3.0%+25.5%−22.5%
2019+15.4%+18.3%−2.8%
2018−6.0%+0.2%−6.2%
2017+11.3%+22.4%−11.2%
2016−2.5%−23.0%+20.5%
2015+6.3%+2.0%+4.2%

Source: Fund prospectus bar charts

Holdings overlap

7 of SHPCX's top 25 holdings also appear in PBE's top 25.

Shared top holdings
HoldingSHPCXPBE
United Therapeutics Corp6.17%4.08%
Amgen Inc5.04%5.22%
Exelixis Inc4.55%2.64%
Gilead Sciences Inc3.94%4.43%
Regeneron Pharmaceuticals Inc3.93%5.47%
Vertex Pharmaceuticals Inc3.36%4.99%
Incyte Corp2.89%3.06%

Source: SEC Form N-PORT

SHPCX top 10

  1. Cardinal Health Inc — 6.44%
  2. Jazz Pharmaceuticals Plc — 6.19%
  3. United Therapeutics Corp — 6.17%
  4. Amgen Inc — 5.04%
  5. Mckesson Corp — 4.90%
  6. Lantheus Holdings Inc — 4.64%
  7. Exelixis Inc — 4.55%
  8. Novartis Ag — 4.50%
  9. Cencora Inc — 4.33%
  10. Gilead Sciences Inc — 3.94%

PBE top 10

  1. Invesco Private Prime Fund — 12.89%
  2. Regeneron Pharmaceuticals, Inc. — 5.47%
  3. Amgen Inc. — 5.22%
  4. CareDx, Inc. — 5.04%
  5. Vertex Pharmaceuticals Inc. — 4.99%
  6. Invesco Private Government Fund — 4.97%
  7. Royalty Pharma PLC — 4.94%
  8. Biogen Inc. — 4.79%
  9. Gilead Sciences, Inc. — 4.43%
  10. United Therapeutics Corp. — 4.08%

FAQ

What is the difference between SHPCX and PBE?
SHPCX (Health & Biotechnology Portfolio) and PBE (Invesco Biotechnology & Genome ETF) are both mutual funds. PBE is cheaper at 0.59% vs 3.6% — a difference of $301 a year per $10,000 invested.
Which is cheaper, SHPCX or PBE?
PBE has the lower expense ratio (0.59%).
Should I own both SHPCX and PBE?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.